🇺🇸 FDA
Patent

US 7888116

Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

granted A61PA61P3/10

Quick answer

US patent 7888116 (Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P3/10